To assess the association between social determinants of health (SDOH) and buprenorphine initiation among justice-involved veterans (JIVs), specifically focusing on demographic subgroups such as age, gender, and prior treatment history, and to estimate the 1-year initiation rate across these subgroups.
Key Findings:
Only 27% of JIVs with prior prison involvement and 34% with jail or court histories receive medications for opioid use disorder (MOUD), highlighting a critical gap in treatment access.
Social determinants of health significantly impact treatment initiation and retention for veterans with OUD, indicating the need for targeted interventions.
Unstructured clinical notes provide richer contextual information about SDOH compared to structured data, suggesting a need for improved data collection methods.
Interpretation:
The study highlights the critical role of SDOH in buprenorphine treatment initiation among JIVs, suggesting that addressing these factors could significantly improve treatment access and outcomes for this vulnerable population.
Limitations:
The study relied on retrospective data, which may not capture all relevant SDOH, potentially leading to an underestimation of their impact.
The findings may not be generalizable to all veterans or non-veterans with OUD, limiting the applicability of the results to broader populations.
Conclusion:
Improving the understanding of SDOH can help address barriers to buprenorphine initiation for justice-involved veterans, ultimately enhancing treatment outcomes and reducing health disparities.
